NURS 6050 Week 1 Policy Agenda Post Example

Week 1 Discussion: Initial Post

How the IV Fluid Shortage Moved From a Nursing Workaround to a National Agenda Item

A condition is something people put up with; a problem is something they expect government to do something about. Kingdon (2011) draws that line in his account of how issues reach the agenda, and it explains why drug shortages lived on hospital units for years before they reached Congress. The issue I chose is the shortage of small-volume intravenous fluid bags, and what interests me is not that it happened but how it moved.

For nurses, shortages of injectable drugs and fluids were a condition long before they were a problem. On my unit and many others, we worked around them in operational terms: swapping a premixed bag for a vial and a syringe, pushing some medications slowly by syringe instead of hanging a small piggyback, borrowing fluids from other units at night, and learning which substitutions pharmacy would approve. Each workaround added steps and chances for error, and each was absorbed into the shift without reaching anyone outside the hospital. ASHP had published guidance on managing shortages for years precisely because they had become routine (Fox & McLaughlin, 2018).

The hinge was a single event that made the condition visible: in September 2017 Hurricane Maria damaged manufacturing plants in Puerto Rico that produced a large share of the country's small-volume saline bags. A shortage that had been an internal hospital nuisance became a national story, with hospitals describing rationing on the evening news and hospital and pharmacy associations writing to members of Congress. Mazer-Amirshahi and Fox (2018) describe how the storm exposed a market with few manufacturers, thin margins, and little redundancy, so that one damaged site could affect patients across the country. In Kingdon's terms, a focusing event opened a policy window.

What kept the issue on the agenda after the coverage faded was that the other two streams were ready. Federal agencies were already tracking shortages; the FDA had a shortage staff and reporting requirements for manufacturers, so there was data and an institutional owner. Proposals drafted in earlier years, about manufacturing incentives, supply-chain transparency, and domestic production, were sitting in reports and bill drafts waiting for a moment. When the window opened, those solutions could be attached to it, and the FDA convened a drug shortages task force whose report on root causes followed. The attention outlasted the storm because it landed on a problem that already had people, data, and proposals waiting for it. I would be curious whether others see the same pattern in their issues: does the event come first, or do the proposals?

Reply to Rachel

Rachel, your issue, nurse fatigue from mandatory overtime, is clearly a condition nurses have tolerated for decades, and your post describes it vividly. I wonder, with the model from Kingdon (2011) in mind, whether it has had its hinge yet. Your post mentions staffing reports and state bills already drafted, which suggests the policy stream is ready, but I did not see a focusing event that turned it into a problem the public expects government to fix. Some states moved on overtime limits after widely reported errors or strikes. Do you think the pandemic served as that event for your state, or is the issue still waiting for one?

References

Fox, E. R., & McLaughlin, M. M. (2018). ASHP guidelines on managing drug product shortages. American Journal of Health-System Pharmacy, 75(21), 1742-1750. https://doi.org/10.2146/ajhp180441

Kingdon, J. W. (2011). Agendas, alternatives, and public policies (Updated 2nd ed.). Longman.

Mazer-Amirshahi, M., & Fox, E. R. (2018). Saline shortages: Many causes, no simple solution. New England Journal of Medicine, 378(16), 1472-1474. https://doi.org/10.1056/NEJMp1800347